Skip to content

Local application of esketamine in the treatment of catheter-related bladder irritation

Local application of esketamine in the treatment of catheter-related bladder irritation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098072
Enrollment
Unknown
Registered
2025-03-03
Start date
2025-03-03
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter-Related Bladder Discomfort

Interventions

SK group:Escitalopram 0.5 mg/kg, diluted to 10 ml, was slowly injected into the bladder through a urinary catheter, which was clamped shut for 20 min and then opened.
NSgroup:Saline 10 ml was slowly injected into the bladder via catheter.

Sponsors

Xiangyang No.1 People’s Hospital Hubei University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade 1 to 3; 2. Preoperative urinary catheterization is required; 3. Male 18 to 60 years of age; 4. BMI < 27.

Exclusion criteria

Exclusion criteria: 1. Allergy or contraindication to the test drug; 2. history of chronic pain; 3. long-term use of analgesic or psychotropic medications; 4. severe hepatic or renal dysfunction; 5. inability to cooperate with the evaluation; 6. intracranial hypertension; 7. severe hypertension (SBP >160 mmHg); 8. difficulty in catheter placement; 9. bladder outflow tract obstruction; 10. neurogenic bladder; 11. Parkinson's disease; 12. Diabetes mellitus; 13. OAB (more than 3 nocturnal urinations or more than 8 urinations in a 24-hour period); transurethral resection of the prostate for benign prostatic hyperplasia; 14. end-stage renal disease (urine output of less than 50 ml per 24 hours); or urinary tract infections.

Design outcomes

Primary

MeasureTime frame
Incidence and severity of postoperative CRBD;

Secondary

MeasureTime frame
sedation level;

Countries

China

Contacts

Public ContactGong Ting

Xiangyang No.1 People’s Hospital Hubei University of Medicine

faby_0606@163.com+86 150 7222 9677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026